New indication of tolvaptan as approved by FDA recently: (A) Phenylketonuria, (B) Pancreatic tumours, (C) Polycystic ovarian disease, (D) Polycystic kidney disease
Answer is D. Tolvaptan is a vasopressin antagonist used for SIADH Now approved for PCKD Ref : HH Sharma 3rd ed.